Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-03

Clinical Trial Update: A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind trial evaluating pentaisomaltose versus dimethyl sulfoxide for cryoprotection of autologous hematopoietic stem cell transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dimethyl Sulphoxide (Dimethyl sulfoxide)
  • Pentaisomaltose

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Malignant Lymphoma, Multiple Myeloma | Phase 4 | Status: NOT_YET_RECRUITING